239 related articles for article (PubMed ID: 26181867)
1. Hepatopancreatobiliary manifestations of inflammatory bowel disease.
Nakamura K; Ito T; Kotoh K; Ihara E; Ogino H; Iwasa T; Tanaka Y; Iboshi Y; Takayanagi R
Clin J Gastroenterol; 2012 Feb; 5(1):1-8. PubMed ID: 26181867
[TBL] [Abstract][Full Text] [Related]
2. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.
Navaneethan U; Shen B
Inflamm Bowel Dis; 2010 Sep; 16(9):1598-619. PubMed ID: 20198712
[TBL] [Abstract][Full Text] [Related]
3. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
4. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
de Vries AB; Janse M; Blokzijl H; Weersma RK
World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
[TBL] [Abstract][Full Text] [Related]
5. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.
Mazza S; Soro S; Verga MC; Elvo B; Ferretti F; Cereatti F; Drago A; Grassia R
World J Hepatol; 2021 Dec; 13(12):1828-1849. PubMed ID: 35069993
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis, Differential Diagnosis, and Epidemiology of Primary Sclerosing Cholangitis.
Ponsioen CY
Dig Dis; 2015; 33 Suppl 2():134-9. PubMed ID: 26640943
[TBL] [Abstract][Full Text] [Related]
7. Geoepidemiology of primary sclerosing cholangitis: a critical review.
Tanaka A; Takikawa H
J Autoimmun; 2013 Oct; 46():35-40. PubMed ID: 23932346
[TBL] [Abstract][Full Text] [Related]
8. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
[TBL] [Abstract][Full Text] [Related]
9. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis.
Nishino T; Oyama H; Hashimoto E; Toki F; Oi I; Kobayashi M; Shiratori K
J Gastroenterol; 2007 Jul; 42(7):550-9. PubMed ID: 17653651
[TBL] [Abstract][Full Text] [Related]
11. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
[TBL] [Abstract][Full Text] [Related]
12. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update.
Rossi RE; Conte D; Massironi S
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):123-31. PubMed ID: 26636407
[TBL] [Abstract][Full Text] [Related]
13. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
Broomé U; Bergquist A
Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
[TBL] [Abstract][Full Text] [Related]
14. Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India.
Singh A; Midha V; Narang V; Kedia S; Mahajan R; Dhoble P; Kahlon BK; Dhaliwal AS; Tripathi A; Kalra S; Jain NP; Bansal N; Banerjee R; Desai D; Dutta U; Ahuja V; Sood A
Intest Res; 2023 Oct; 21(4):452-459. PubMed ID: 36453008
[TBL] [Abstract][Full Text] [Related]
15. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune pancreatitis and primary sclerosing cholangitis in a 16-year-old boy with inflammatory bowel disease.
Huelsen A; Bailey W; Whitehead M; Chalmers-Watson T
Clin J Gastroenterol; 2012 Apr; 5(2):131-5. PubMed ID: 26182156
[TBL] [Abstract][Full Text] [Related]
17. Sclerosing cholangitis associated with autoimmune pancreatitis.
Kawa S; Hamano H; Umemura T; Kiyosawa K; Uehara T
Hepatol Res; 2007 Oct; 37 Suppl 3():S487-95. PubMed ID: 17931208
[TBL] [Abstract][Full Text] [Related]
18. IgG4 subclass and gamma-glutamyl transferase in children with ulcerative colitis with primary sclerosing cholangitis and without sclerosing cholangitis.
Farahmand F; Ahmadi M; Khodadad A; Najafi M; Fallahi G; Motamed F; Movahedi M; Aghamohammadi A; Rezaei N; Javaherizadeh H
Clin Exp Hepatol; 2019 Nov; 5(4):285-288. PubMed ID: 31893239
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
Rojas-Feria M; Castro M; Suárez E; Ampuero J; Romero-Gómez M
World J Gastroenterol; 2013 Nov; 19(42):7327-40. PubMed ID: 24259964
[TBL] [Abstract][Full Text] [Related]
20. PSC, AIH and overlap syndrome in inflammatory bowel disease.
Trivedi PJ; Chapman RW
Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):420-36. PubMed ID: 22306055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
